logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

AntineoplasticsMyelosuppression, right lower extremity skin ulcerations secondary to off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1841卷 / 1期
关键词:
D O I:
10.1007/s40278-021-90536-z
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:34 / 34
相关论文
共 50 条
  • [41] BevacizumabRetinal breaks and off-label use: case report
    Reactions Weekly, 2022, 1924 (1) : 120 - 120
  • [42] Mirtazapine/pregabalinDelirium and off-label use: case report
    Reactions Weekly, 2024, 2029 (1) : 384 - 384
  • [43] DexamethasoneHyperglycaemia following off-label use: case report
    Reactions Weekly, 2022, 1896 (1) : 173 - 173
  • [44] DexamfetamineHypertension following off-label use: case report
    Reactions Weekly, 2021, 1883 (1) : 150 - 150
  • [45] FavipiravirNephrotoxicity following off-label use: case report
    Reactions Weekly, 2022, 1929 (1) : 283 - 283
  • [46] MirtazapineTachyphylaxis following off-label use: case report
    Reactions Weekly, 2018, 1703 (1) : 182 - 182
  • [47] RisdiplamPneumonia following off-label use: case report
    Reactions Weekly, 2023, 1950 (1) : 348 - 348
  • [48] CanagliflozinFanconi syndrome and off-label use: case report
    Reactions Weekly, 2020, 1787 (1) : 130 - 130
  • [49] RivoceranibNeurotoxicity following an off-label use: case report
    Reactions Weekly, 2018, 1702 (1) : 232 - 232
  • [50] HydroxychloroquineLack of efficacy and off-label use: case report
    Reactions Weekly, 2022, 1925 (1) : 264 - 264
← 12345 →